Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Enterprise Value (2016 - 2025)

Firefly Neuroscience has reported Enterprise Value over the past 15 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$2.7 million for Q4 2025, down 51.77% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (down 51.77% YoY), and the annual figure for FY2025 was -$2.7 million, down 51.77%.
  • Enterprise Value for Q4 2025 was -$2.7 million at Firefly Neuroscience, up from -$4.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for AIFF hit a ceiling of -$58000.0 in Q4 2022 and a floor of -$9.5 million in Q1 2025.
  • Median Enterprise Value over the past 5 years was -$1.6 million (2024), compared with a mean of -$2.5 million.
  • Biggest five-year swings in Enterprise Value: surged 98.82% in 2022 and later plummeted 3594.83% in 2023.
  • Firefly Neuroscience's Enterprise Value stood at -$4.9 million in 2021, then surged by 98.82% to -$58000.0 in 2022, then plummeted by 3594.83% to -$2.1 million in 2023, then rose by 15.54% to -$1.8 million in 2024, then plummeted by 51.77% to -$2.7 million in 2025.
  • The last three reported values for Enterprise Value were -$2.7 million (Q4 2025), -$4.3 million (Q3 2025), and -$5.9 million (Q2 2025) per Business Quant data.